What You’ll Do
- Lead the development of comprehensive market access strategies for pharmaceutical products, focusing on U.S. payers, PBMs (Pharmacy Benefit Managers), Medicare, and Medicaid.
- Utilize real-world evidence, healthcare claims data, and advanced analytics tools to drive decision-making around pricing, contracting, and patient access strategies.
- Design and execute analyses related to payer coverage, formulary inclusion, and reimbursement challenges.
- Create and deliver executive-level presentations with clear, data-driven insights that inform actionable strategies.
- Lead and manage client projects related to access and affordability strategy, ensuring timely delivery and alignment with the client’s strategic objectives.
- Manage deliverables including presentations, white papers, and detailed analytical reports
- Stay updated on U.S. health policy changes, including regulations from CMS (Centers for Medicare and Medicaid Services) and other bodies that affect pricing and access
- Analyze the potential impact of evolving healthcare policies on pricing and reimbursement strategies and communicate those insights to clients.
What You’ll Bring
- 5-8 years of experience in analytics and strategic consulting within U.S. healthcare, market access, and value-based care.
- Strong technical expertise in SQL, Python and MS Excel for data management and analysis.
- Strong storyboarding skills for unstructured problems and data.
- Strong expertise in US healthcare datasets such as anonymized patient level data, EMR, etc.
- Skilled in data analytics and statistical modeling, simplifying complex data insights into actionable business strategies.
- Exceptional problem-solving and critical thinking abilities, driving innovative solutions.
- Proven communication skills, with the ability to effectively engage and collaborate with internal teams and external clients.
- Demonstrated leadership in team and project management, overseeing successful project execution.
- Extensive knowledge of the U.S. healthcare ecosystem, industry trends, and pharmaceutical data sources, including sales, patient claims, and formulary data.